We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
-1.1%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$78.9B
AUM Growth
+$522M
Cap. Flow
+$1.98B
Cap. Flow %
2.5%
Top 10 Hldgs %
13.37%
Holding
702
New
56
Increased
268
Reduced
333
Closed
31

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$552M
2
BA icon
Boeing
BA
+$226M
3
ORCL icon
Oracle
ORCL
+$190M
4
CB icon
Chubb
CB
+$176M
5
NVS icon
Novartis
NVS
+$172M

Sector Composition

Rank Sector Weight
1 Financials 21.51%
2 Industrials 14.85%
3 Technology 14.38%
4 Healthcare 14.3%
5 Consumer Discretionary 11.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HWM icon
26
Howmet Aerospace
HWM
$116B
$636M 0.81%
20,363,771
+1,213,850
+6% +$39.1M
AIG icon
27
American International
AIG
$41.9B
$627M 0.79%
11,423,788
+46,445
+0.4% +$2.39M
CCEP icon
28
Coca-Cola Europacific Partners
CCEP
$46.5B
$627M 0.79%
11,342,275
+1,099,635
+11% +$65.4M
LKQ icon
29
LKQ Corp
LKQ
$6.58B
$624M 0.79%
12,396,102
+310,606
+3% +$15.8M
MHK icon
30
Mohawk Industries
MHK
$6.9B
$607M 0.77%
3,419,051
+222,227
+7% +$43.1M
SCHW
31
Charles Schwab
SCHW
$177B
$606M 0.77%
8,315,507
+144,811
+2% +$10.3M
CNC icon
32
Centene
CNC
$31.3B
$593M 0.75%
9,520,749
+165,333
+2% +$11M
AMP icon
33
Ameriprise Financial
AMP
$46.8B
$592M 0.75%
2,239,719
+61,401
+3% +$16.1M
NXPI icon
34
NXP Semiconductors
NXPI
$68B
$592M 0.75%
3,020,862
-211,690
-7% -$44M
CNP icon
35
CenterPoint Energy
CNP
$29.1B
$586M 0.74%
23,801,781
+333,359
+1% +$8.53M
PFE icon
36
Pfizer
PFE
$140B
$585M 0.74%
13,594,007
+209,908
+2% +$9.3M
EG icon
37
Everest Group
EG
$15.2B
$578M 0.73%
2,302,362
-78,314
-3% -$20.1M
COR icon
38
Cencora
COR
$60.3B
$572M 0.72%
4,788,604
+82,358
+2% +$9.89M
GD icon
39
General Dynamics
GD
$105B
$571M 0.72%
2,912,849
+294,563
+11% +$57.7M
ICLR icon
40
Icon
ICLR
$12.8B
$565M 0.72%
2,155,437
+1,046,263
+94% +$254M
QCOM icon
41
Qualcomm
QCOM
$176B
$562M 0.71%
4,361,379
+1,670,821
+62% +$237M
ABBV icon
42
AbbVie
ABBV
$458B
$546M 0.69%
5,060,309
+589,506
+13% +$67.4M
COF icon
43
Capital One
COF
$124B
$542M 0.69%
3,344,687
+296,511
+10% +$48.4M
META icon
44
Meta Platforms (Facebook)
META
$1.51T
$525M 0.66%
1,546,750
+121,436
+9% +$43.7M
MU icon
45
Micron Technology
MU
$1.04T
$514M 0.65%
7,242,387
+449,491
+7% +$33.8M
MCK icon
46
McKesson
MCK
$98.5B
$504M 0.64%
2,527,992
+65,607
+3% +$13.1M
HOG icon
47
Harley-Davidson
HOG
$2.68B
$501M 0.63%
13,682,239
+901,026
+7% +$36.3M
TXT icon
48
Textron
TXT
$16.6B
$498M 0.63%
7,127,695
+176,351
+3% +$12.4M
TEL icon
49
TE Connectivity
TEL
$58.8B
$491M 0.62%
3,574,350
+136,105
+4% +$19.6M
AMAT icon
50
Applied Materials
AMAT
$426B
$478M 0.61%
3,713,071
-737,997
-17% -$100M

Similar funds

Boston Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Boston Partners held 702 positions worth $78.9B, up 0.67% from $78.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Boston Partners's Q3 2021 filing shows 56 new, 268 increased, 333 reduced and 31 closed positions. Its largest new stake was Global Payments: 2,796,841 shares worth $441M. The largest sale was Elevance Health, an estimated $552M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Industrials and Technology.

  • Boston Partners's largest Q3 2021 buy was Global Payments: 2,796,841 shares worth $441M.
  • Boston Partners added most to Activision Blizzard in Q3 2021, an estimated $314M increase.
  • Boston Partners's biggest Q3 2021 reduction was Elevance Health, cutting an estimated $552M.
  • Boston Partners fully exited Cummins in Q3 2021, selling an estimated $161M.
  • Boston Partners's ten largest holdings make up 13% of its $78.9B portfolio in Q3 2021.
  • Boston Partners opened 56 new positions and closed 31 in Q3 2021.
  • Boston Partners's portfolio value rose 0.67% quarter-over-quarter to $78.9B.

Based on Boston Partners's 13F filing for Q3 2021, filed 5 Nov 2021.